The global cell analysis market was valued at an estimated $16.7 billion in 2013 and is expected to reach $23.0 billion by 2018, growing at a CAGR of 6.6% from 2013 to 2018.
Dallas, Texas (PRWEB) April 15, 2014
The global cell analysis market is a technology-driven market and is marked by the ‘Threat of Obsolescence,’ wherein technologies as well as their adoption by end users changes very rapidly. Hospitals, academic and government institutes, as well as pharmaceutical and biotechnology companies are increasing their focus on using cell analysis as a powerful research tool in research, drug discovery, and diagnosis. The cell analysis instruments market is the fastest-growing segment in the cell analysis market. In cell analysis, the accuracy of the results obtained depends on the quality of consumables, instruments, and data management software. In the recent years, advanced cell image analysis and data management solutions have been introduced, but there is scope for further improvement of these solutions. Many of the key players in the cell analysis instruments market are collaborating with companies and academic institutes in order to offer products with better software. For instance, in February 2014, Agilent Technologies (U.S.) collaborated with Cell Line Genetics (U.S.) for high throughput screening of cell line characterization services for regenerative medicine. Cell Line Genetics will develop high throughput, genomic characterizations to confirm and monitor the integrity of a cell line for translational and regenerative medicine research by using Agilent’s technologies.
Complete Report available at http://www.rnrmarketresearch.com/cell-analysis-market-by-instruments-flow-cytometer-microscope-microfluidics-qpcr-consumables-application-cell-identification-cell-viability-cell-proliferation-cytology-signal-transduction-market-report.html .
In the coming years, Asian countries are expected to witness a high growth. These regions offer an array of opportunities for growth and are expected to be the new revenue pockets for players in the cell analysis market. These regions offer a high-growth potential as compared to mature markets such as the U.S. Growth in the Asian market is spurred by government support for the development of innovative screening technologies and rising demand for outsourcing of drug discovery services. For instance, in September 2013, the Global Health Innovative Technology Fund (GHIT Fund) granted $5.7 million to six global partnerships, to support their R&D activities, in the area of various infectious diseases like tuberculosis, malaria, and Chagas disease. Such funding is expected to boost the growth of the cell analysis market.
The global cell analysis market is a highly competitive market and all the existing players in this market are engaged in developing new and advanced products to maintain their market shares.
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help the firms in garnering a greater market share. Firms purchasing this report could use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for reaping a greater market share.
Inquire for Discount @ http://www.rnrmarketresearch.com/contacts/discount?rname=167416 .
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the product portfolios and services offered by the top players in the cell analysis market. The report analyzes the cell analysis market by application across geographies.
- Product Development/Innovation: Detailed insights on research and development activities and new product launches in the cell analysis market.
- Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes promising applications of the cell analysis market by product across geographies
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cell analysis market
- Competitive Assessment: In-depth assessment of strategies, products and services, and distribution networks in the cell analysis market
Major points from Table of Content
9 Company Profiles (Overview, Financials, Products & Services, Strategy, & Developments)
9.1 Beckton, Dickinson and Company
9.2 Danaher Corporation
9.3 Sigma-Aldrich Corporation
9.4 Thermo Fisher Scientific, Inc.
9.5 Agilent Technologies, Inc.
9.6 GE Healthcare
9.7 Merck KGAA
9.8 Olympus Corpopration
9.9 Perkinelmer, Inc.
9.10 Promega Corporation
Order a copy of this report at http://www.rnrmarketresearch.com/contacts/purchase?rname=167416 .
Browse more reports on Biotechnology Market @ http://www.rnrmarketresearch.com/reports/life-sciences/biotechnology .
RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.